Full text is available at the source.
Abstract
Exosomes have the potential to improve therapeutic delivery due to their ability to cross the blood-brain barrier.
- Exosomes are nanoscale vesicles that can carry a variety of bioactive molecules, including nucleic acids and drugs.
- Current challenges in using exosomes for therapy include low production yield and limited capacity to load drugs.
- Engineered hybrid nanoparticles, created by fusing exosomes with liposomes, may enhance stability and loading efficiency.
- Hybrid exosome-liposome nanoparticles (HELNs) show promise for improved therapeutic performance in cancer treatments.
- The review discusses biological properties of exosomes and recent advancements in their application in drug delivery and immunotherapy.
Simplified